RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors
0 Tampilan
• 07/08/23
0
0
Menanamkan
administrator
Pelanggan
Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.
For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru